Idiopathic Pulmonary Fibrosis
Plain language summary: Clinical study of BI 1015550 as a potential treatment for idiopathic pulmonary fibrosis
J Comp Eff Res. 2022 Dec 20. doi: 10.2217/cer-2022-0142. Online ahead of print.
NO ABSTRACT
PMID:36537726 | DOI:10.2217/cer-2022-0142
Response to "Hiatal hernia and idiopathic pulmonary fibrosis"
Tuberk Toraks. 2022 Dec;70(4):407-408. doi: 10.5578/tt.20229615.
NO ABSTRACT
PMID:36537101 | DOI:10.5578/tt.20229615
Hiatal hernia and idiopathic pulmonary fibrosis
Tuberk Toraks. 2022 Dec;70(4):405-406. doi: 10.5578/tt.20229614.
NO ABSTRACT
PMID:36537100 | DOI:10.5578/tt.20229614
Diverse Functions of Apolipoprotein A-I in Lung Fibrosis
Am J Physiol Cell Physiol. 2022 Dec 19. doi: 10.1152/ajpcell.00491.2022. Online ahead of print.
NO ABSTRACT
PMID:36534503 | DOI:10.1152/ajpcell.00491.2022
Fibrotic Lung Disease Alters Neutrophil Trafficking and Promotes Neutrophil Elastase and Extracellular Trap Release
Immunohorizons. 2022 Dec 1;6(12):817-834. doi: 10.4049/immunohorizons.2200083.
NO ABSTRACT
PMID:36534439 | DOI:10.4049/immunohorizons.2200083
Serum Krebs von den Lungen-6: promising biomarker to differentiate CPFE from IPF
Sarcoidosis Vasc Diffuse Lung Dis. 2022 Dec 19;39(4):e2022035. doi: 10.36141/svdld.v39i4.11344.
NO ABSTRACT
PMID:36533605 | DOI:10.36141/svdld.v39i4.11344
Intravenous immunoglobulin for acute exacerbation of fibrotic idiopathic interstitial pneumonias
Sarcoidosis Vasc Diffuse Lung Dis. 2022 Dec 19;39(4):e2022038. doi: 10.36141/svdld.v39i4.13682.
NO ABSTRACT
PMID:36533600 | DOI:10.36141/svdld.v39i4.13682
Idiopathic pulmonary fibrosis and intestinal disorders: An observational study
Ann Diagn Pathol. 2022 Dec 5:152072. doi: 10.1016/j.anndiagpath.2022.152072. Online ahead of print.
NO ABSTRACT
PMID:36529590 | DOI:10.1016/j.anndiagpath.2022.152072
Organising our thoughts
Evid Based Dent. 2022 Dec;23(4):128. doi: 10.1038/s41432-022-0842-x. Epub 2022 Dec 16.
NO ABSTRACT
PMID:36526830 | DOI:10.1038/s41432-022-0842-x
Epigenetic Regulation of IPF Fibroblast Phenotype by Glutaminolysis
Mol Metab. 2022 Dec 13:101655. doi: 10.1016/j.molmet.2022.101655. Online ahead of print.
NO ABSTRACT
PMID:36526153 | DOI:10.1016/j.molmet.2022.101655
SARC-F scores can predict health status and daily activity in patients with idiopathic pulmonary fibrosis
J Thorac Dis. 2022 Nov;14(11):4309-4318. doi: 10.21037/jtd-22-813.
NO ABSTRACT
PMID:36524076 | PMC:PMC9745519 | DOI:10.21037/jtd-22-813
Prognostic analysis of m6A-related genes as potential biomarkers in idiopathic pulmonary fibrosis
Front Genet. 2022 Nov 29;13:1059325. doi: 10.3389/fgene.2022.1059325. eCollection 2022.
NO ABSTRACT
PMID:36523766 | PMC:PMC9744785 | DOI:10.3389/fgene.2022.1059325
Analysis of the safety and efficacy of different plasma concentrations of pirfenidone in patients with idiopathic pulmonary fibrosis
Front Pharmacol. 2022 Nov 29;13:1055702. doi: 10.3389/fphar.2022.1055702. eCollection 2022.
NO ABSTRACT
PMID:36523502 | PMC:PMC9744780 | DOI:10.3389/fphar.2022.1055702
Lung cancer in pulmonary fibrosis: no room for nihilism!
Eur Respir J. 2022 Dec 15;60(6):2201946. doi: 10.1183/13993003.01946-2022. Print 2022 Dec.
NO ABSTRACT
PMID:36522141 | DOI:10.1183/13993003.01946-2022
Radotinib attenuates TGFβ -mediated pulmonary fibrosis in vitro and in vivo: exploring the potential of drug repurposing
BMC Pharmacol Toxicol. 2022 Dec 15;23(1):93. doi: 10.1186/s40360-022-00634-x.
NO ABSTRACT
PMID:36522756 | DOI:10.1186/s40360-022-00634-x
TGF-β1 Regulates Peroxisomal Genes/Proteins via Smad Signaling in Idiopathic Pulmonary Fibrosis Fibroblasts and Transgenic Mouse Models
Am J Pathol. 2022 Dec 12:S0002-9440(22)00392-3. doi: 10.1016/j.ajpath.2022.11.006. Online ahead of print.
NO ABSTRACT
PMID:36521562 | DOI:10.1016/j.ajpath.2022.11.006
NF-κB drives epithelial-mesenchymal mechanisms of lung fibrosis in a translational lung cell model
JCI Insight. 2022 Dec 15:e154719. doi: 10.1172/jci.insight.154719. Online ahead of print.
NO ABSTRACT
PMID:36520540 | DOI:10.1172/jci.insight.154719
Effect of M6A regulators on diagnosis, subtype classification, prognosis and novel therapeutic target development of idiopathic pulmonary fibrosis
Front Pharmacol. 2022 Nov 28;13:993567. doi: 10.3389/fphar.2022.993567. eCollection 2022.
NO ABSTRACT
PMID:36518679 | PMC:PMC9742476 | DOI:10.3389/fphar.2022.993567
Oral arsenic trioxide for treating acute promyelocytic leukaemia: Implications for its worldwide epidemiology and beyond
Front Oncol. 2022 Nov 18;12:1026478. doi: 10.3389/fonc.2022.1026478. eCollection 2022.
NO ABSTRACT
PMID:36518307 | PMC:PMC9744132 | DOI:10.3389/fonc.2022.1026478
Progressive pulmonary fibrosis: an expert group consensus statement
Eur Respir J. 2022 Dec 14:2103187. doi: 10.1183/13993003.03187-2021. Online ahead of print.
NO ABSTRACT
PMID:36517177 | DOI:10.1183/13993003.03187-2021